Cargando…
Widespread Aberrant Alternative Splicing despite Molecular Remission in Chronic Myeloid Leukaemia Patients
SIMPLE SUMMARY: This study provides new insights into the changing transcriptomic and epigenomic landscapes in chronic myeloid leukaemia (CML) patients who are receiving tyrosine kinase inhibitor (TKI) therapy (often life-long). Alternative splicing, vital for cellular homeostasis, is dysregulated i...
Autores principales: | Schmitz, Ulf, Shah, Jaynish S., Dhungel, Bijay P., Monteuuis, Geoffray, Luu, Phuc-Loi, Petrova, Veronika, Metierre, Cynthia, Nair, Shalima S., Bailey, Charles G., Saunders, Verity A., Turhan, Ali G., White, Deborah L., Branford, Susan, Clark, Susan J., Hughes, Timothy P., Wong, Justin J.-L., Rasko, John E.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764299/ https://www.ncbi.nlm.nih.gov/pubmed/33322625 http://dx.doi.org/10.3390/cancers12123738 |
Ejemplares similares
-
The Fusion of CLEC12A and MIR223HG Arises from a trans-Splicing Event in Normal and Transformed Human Cells
por: Dhungel, Bijay P., et al.
Publicado: (2021) -
Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA
por: Skvortsova, Ksenia, et al.
Publicado: (2017) -
The changing paradigm of intron retention: regulation, ramifications and recipes
por: Monteuuis, Geoffray, et al.
Publicado: (2019) -
S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA
por: Kok, Chung, et al.
Publicado: (2023) -
Benchmark study comparing liftover tools for genome conversion of epigenome sequencing data
por: Luu, Phuc-Loi, et al.
Publicado: (2020)